M. Lorenz

1.5k citations

52 papers · 1.1k indexed · h-index 17

Impact in

Endocrinology, Diabetes and Metabolism top 5%
- Diabetes Treatment and Management
- Diabetes Management and Research
Hematology top 10%
- Blood Coagulation and Thrombosis Mechanisms

Papers in ⓘ

Hematology 14
- Blood Coagulation and Thrombosis Mechanisms 10
Anesthesiology and Pain Medicine 4
- Anesthesia and Sedative Agents 3

Co-authors: Michael Wagner (6 shared papers)Andreas Evers (5 shared papers)M. R. Gaab (5 shared papers)Hans E. Heissler (1 shared paper)Volker Laux (5 shared papers)Herman Schreuder (8 shared papers)Peter Ruus (1 shared paper)R. H. A. Becker (1 shared paper)
Journals: Bioorganic & Medicinal Chemistry Letters (6 papers)Journal of Medicinal Chemistry (4 papers)Thrombosis and Haemostasis (2 papers)Diabetes Obesity and Metabolism (2 papers)Journal of Neurosurgical Anesthesiology (1 paper)
Partner nations: Germany United States France

In The Last Decade

M. Lorenz

50 papers receiving 1.1k citations

Peers

Countries citing papers authored by M. Lorenz

Since Specialization

Citations

This map shows the geographic impact of M. Lorenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Lorenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Lorenz more than expected).

Fields of papers citing papers by M. Lorenz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Lorenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Lorenz. The network helps show where M. Lorenz may publish in the future.

Co-authors

The 25 scholars most cited alongside M. Lorenz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. Lorenz Line = papers co-authored together M. Lorenz links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Effects of lixisenatide once daily on gastric emptying in type 2 diabetes — Relationship to postprandial glycemia Regulatory Peptides ·M. Lorenz, Claudia Pfeiffer, Axel Steinsträßer, R. H. A. Becker, Hartmut Rütten, Peter Ruus, Michael Horowitz	2013	122
2	Differential effects of glucagon-like peptide-1 receptor agonists on heart rate Cardiovascular Diabetology ·M. Lorenz, Francesca Lawson, David R. Owens, D. Raccah, Christine Roy-Duval, Anne Lehmann, Riccardo Perfetti, Lawrence Blonde	2017	113
3	Probing the Subpockets of Factor Xa Reveals Two Binding Modes for Inhibitors Based on a 2-Carboxyindole Scaffold: A Study Combining Structure-Activity Relationship and X-ray Crystallography Journal of Medicinal Chemistry ·Marc Nazaré, David W. Will, Hans Matter, Herman Schreuder, Kurt Ritter, Matthias Urmann, Melanie Essrich, Armin Bauer, Michael Wagner, Jörg Czech, M. Lorenz, Volker Laux, Volkmar Wehner	2005	96
4	Traumatic Brain Swelling and Operative Decompression: A Prospective Investigation PubMed ·M. R. Gaab, Marion Rittierodt, M. Lorenz, Hans E. Heissler	1990	95
5	Recent progress and future options in the development of GLP-1 receptor agonists for the treatment of diabesity Bioorganic & Medicinal Chemistry Letters ·M. Lorenz, Andreas Evers, Michael Wagner	2013	95
6	Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists Journal of Medicinal Chemistry ·Andreas Evers, Torsten Haack, M. Lorenz, Martin Bossart, Ralf Elvert, Bernd Henkel, Siegfried Stengelin, Michael Kurz, Maike Glien, Angela Dudda, Katrin Lorenz, Dieter Kadereit, Michael Wagner	2017	89
7	Description of the chemical and pharmacological characteristics of a new hemisynthetic ultra‐low‐molecular‐weight heparin, AVE5026 Journal of Thrombosis and Haemostasis ·Christian Viskov, Melitta Just, Volker Laux, Pierre Mourier, M. Lorenz	2009	50
8	Effects on Molecular Conformation and Anticoagulant Activities of 1,6-Anhydrosugars at the Reducing Terminal of Antithrombin-Binding Octasaccharides Isolated from Low-Molecular-Weight Heparin Enoxaparin Journal of Medicinal Chemistry ·Marco Guerrini, Stefano Elli, Davide Gaudesi, Giangiacomo Torri, Benito Casu, Pierre Mourier, Frédéric Herman, Christian Boudier, M. Lorenz, Christian Viskov	2010	44
9	Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists Specifically Optimized for Multidose Formulations Journal of Medicinal Chemistry ·Andreas Evers, Martin Bossart, Stefania Pfeiffer‐Marek, Ralf Elvert, Herman Schreuder, Michael Kurz, Siegfried Stengelin, M. Lorenz, Andreas W. Herling, Anish Konkar, Ulrike Lukasczyk, Anja Pfenninger, Katrin Lorenz, Torsten Haack, Dieter Kadereit, Michael Wagner	2018	40
10	Running on mixed fuel‐dual agonistic approach of GLP‐1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: A comparative study between mice and non‐human primates Diabetes Obesity and Metabolism ·Ralf Elvert, Andreas W. Herling, Martin Bossart, Tilo Weiß, Baohong Zhang, Pierre Wenski, Jörn Wandschneider, Sabrina Kleutsch, Uwe Butty, Aimo Kannt, Michael Wagner, Torsten Haack, Andreas Evers, Angela Dudda, M. Lorenz, Stefanie Keil, Philip J. Larsen	2018	30
11	Neuronavigational guidance in craniofacial approaches for large (para)nasal tumors involving the anterior skull base and upper clival lesions European Journal of Surgical Oncology ·Makoto Nakamura, Timo Stöver, Thomas Rodt, Omid Majdani, M. Lorenz, Thomas Lenarz, Joachim K. Krauss	2008	25
12	Design, synthesis, and structure–activity relationship of a new class of amidinophenylurea-based factor VIIa inhibitors Bioorganic & Medicinal Chemistry Letters ·Otmar Klingler, Hans Matter, Manfred Schudok, Sanjay Bajaj, Joerg Czech, M. Lorenz, H. Peter Nestler, Herman Schreuder, Peter Wildgoose	2003	23
13	The expanding clinical spectrum of Anderson–Fabry disease: a challenge to diagnosis in the novel era of enzyme replacement therapy Journal of Internal Medicine ·Anna Hauser, M. Lorenz, Gere Sunder‐Plassmann	2004	22
14	Placement of Intraventricular Catheters Using Flexible Electromagnetic Navigation and a Dynamic Reference Frame: A New Technique Stereotactic and Functional Neurosurgery ·Thomas Rodt, Gregory Köppen, M. Lorenz, Omid Majdani, Martin Leinung, Soenke H. Bartling, Jan Kaminsky, Joachim K. Krauss	2007	19
15	Team Players or Opponents: Coadministration of Selective Glucagon and GLP-1 Receptor Agonists in Obese Diabetic Monkeys Endocrinology ·Ralf Elvert, Martin Bossart, Andreas W. Herling, Tilo Weiß, Baohong Zhang, Aimo Kannt, Michael Wagner, Torsten Haack, Andreas Evers, Angela Dudda, Stefanie Keil, M. Lorenz, Katrin Lorenz, Michela Riz, Wolfgang Hennerici, Philip J. Larsen	2018	19
16	Custom chemical microarray production and affinity fingerprinting for the S1 pocket of factor VIIa Analytical Biochemistry ·Stefan Dickopf, Michael Frank, Hans-Dieter Junker, Sabine Maier, Günther Metz, Holger Ottleben, Harald K. Rau, Nathalie Schellhaas, Kristina Schmidt, Renate Sekul, Cécile Vanier, Dirk Vetter, Jörg Czech, M. Lorenz, Hans Matter, Manfred Schudok, Herman Schreuder, David W. Will, H. Peter Nestler	2004	17
17	Association between the Thr325Ile polymorphism of the thrombinactivatable fibrinolysis inhibitor and stroke in the Ludwigshafen Risk and Cardiovascular Health Study Thrombosis and Haemostasis ·M. Lorenz, Winfried März, Emmanuelle Cousin, Sandrine Macé, Jean‐François Deleuze, Detlef Kozian	2010	16
18	Accumulation of radiolabelled platelets and fibrin on the carotid artery of rabbits after angioplasty: effects of heparin and dipyridamole Thrombosis and Haemostasis ·M. Lorenz, Herbert Merk, Michael R. Buchanan, Wolfgang G. Eisert, Joanne van Ryn	2003	16
19	Structure-based design of amidinophenylurea-derivatives for factor VIIa inhibition Bioorganic & Medicinal Chemistry Letters ·Otmar Klingler, Hans Matter, Manfred Schudok, Monica Donghi, Joerg Czech, M. Lorenz, H. Peter Nestler, Hauke Szillat, Herman Schreuder	2004	15
20	Oversulfated Chondroitin Sulfate and OSCS-Contaminated Heparin Cause Dose- and Route-Dependent Hemodynamic Effects in the Rat Toxicological Sciences ·Alain Corbier, N. Le Berre, David Rampe, Harry Meng, M. Lorenz, Pascale Vicat, Sophie Potdevin, Michel Doubovetzky	2011	14

About M. Lorenz

M. Lorenz is a scholar working on Hematology, Anesthesiology and Pain Medicine, Endocrinology, Diabetes and Metabolism, Dermatology and Internal Medicine, having authored 52 papers that have together received 1.1k indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (10 papers), Diabetes Treatment and Management (9 papers), Diabetes Management and Research (3 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Vitamin K Research Studies (3 papers), Anesthesia and Sedative Agents (3 papers), Metabolism, Diabetes, and Cancer (3 papers) and Atrial Fibrillation Management and Outcomes (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (436 citations), Hematology (140 citations), Internal Medicine (40 citations), Neurology (130 citations) and Cellular and Molecular Neuroscience (129 citations). M. Lorenz has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Michael Wagner, Andreas Evers, M. R. Gaab, Hans E. Heissler, Volker Laux, Herman Schreuder, Peter Ruus, R. H. A. Becker, Michael Horowitz and Hartmut Rütten. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Thrombosis and Haemostasis, Diabetes Obesity and Metabolism and Journal of Neurosurgical Anesthesiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact